Skip to main content

Advertisement

Log in

Cellular and molecular mechanisms of alcohol-induced osteopenia

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Alcoholic beverages are widely consumed, resulting in a staggering economic cost in different social and cultural settings. Types of alcohol consumption vary from light occasional to heavy, binge drinking, and chronic alcohol abuse at all ages. In general, heavy alcohol consumption is widely recognized as a major epidemiological risk factor for chronic diseases and is detrimental to many organs and tissues, including bones. Indeed, recent findings demonstrate that alcohol has a dose-dependent toxic effect in promoting imbalanced bone remodeling. This imbalance eventually results in osteopenia, an established risk factor for osteoporosis. Decreased bone mass and strength are major hallmarks of osteopenia, which is predominantly attributed not only to inhibition of bone synthesis but also to increased bone resorption through direct and indirect pathways. In this review, we present knowledge to elucidate the epidemiology, potential pathogenesis, and major molecular mechanisms and cellular effects that underlie alcoholism-induced bone loss in osteopenia. Novel therapeutic targets for correcting alcohol-induced osteopenia are also reviewed, such as modulation of proinflammatory cytokines and Wnt and mTOR signaling and the application of new drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Miranda RC, Pietrzykowski AZ, Tang Y et al (2010) MicroRNAs: master regulators of ethanol abuse and toxicity. Alcohol Clin Exp Res 34:575–587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chakkalakal DA (2005) Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 29:2077–2090

    Article  PubMed  Google Scholar 

  3. Jonsson IM, Verdrengh M, Brisslert M et al (2007) Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci USA 104:258–263

    Article  CAS  PubMed  Google Scholar 

  4. Callaci JJ, Juknelis D, Patwardhan A, Wezeman FH (2006) Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone. Alcohol Clin Exp Res 30:665–672

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sampson HW (2002) Alcohol and other factors affecting osteoporosis risk in women. Alcohol Res Health 26:292–298

    PubMed  Google Scholar 

  6. Turner RT (2000) Skeletal response to alcohol. Alcohol Clin Exp Res 24:1693–1701

    Article  CAS  PubMed  Google Scholar 

  7. Callaci JJ, Himes R, Lauing K, Roper P (2010) Long-term modulations in the vertebral transcriptome of adolescent-stage rats exposed to binge alcohol. Alcohol Alcohol 45:332–346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dyer SA, Buckendahl P, Sampson HW (1998) Alcohol consumption inhibits osteoblastic cell proliferation and activity in vivo. Alcohol 16:337–341

    Article  CAS  PubMed  Google Scholar 

  9. Turner RT, Sibonga JD (2001) Effects of alcohol use and estrogen on bone. Alcohol Res Health 25:276–281

    CAS  PubMed  Google Scholar 

  10. Duggal S, Simpson ME, Keiver K (2007) Effect of chronic ethanol consumption on the response of parathyroid hormone to hypocalcemia in the pregnant rat. Alcohol Clin Exp Res 31:104–112

    Article  CAS  PubMed  Google Scholar 

  11. Howe KS, Iwaniec UT, Turner RT (2011) The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse. Osteoporos Int 22:1175–1181

    Article  CAS  PubMed  Google Scholar 

  12. Wezeman FH, Gong Z (2001) Bone marrow triglyceride accumulation and hormonal changes during long-term alcohol intake in male and female rats. Alcohol Clin Exp Res 25:1515–1522

    Article  CAS  PubMed  Google Scholar 

  13. Dai J, Lin D, Zhang J et al (2000) Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Investig 106:887–895

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mercer KE, Wynne RA, Lazarenko OP et al (2012) Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther 343:401–412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Drake MT, Clarke BL, Khosla S (2008) Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 83:1032–1045

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Frost M, Wraae K, Gudex C et al (2012) Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing 41:177–183

    Article  PubMed  Google Scholar 

  17. Williams FM, Cherkas LF, Spector TD, MacGregor AJ (2005) The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Ann Rheum Dis 64:309–310

    Article  CAS  PubMed  Google Scholar 

  18. Ganry O, Baudoin C, Fardellone P (2000) Effect of alcohol intake on bone mineral density in elderly women: the EPIDOS study. Am J Epidemiol 151:773–780

    Article  CAS  PubMed  Google Scholar 

  19. McGuire S (2011) U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2:293–294

    Article  PubMed  PubMed Central  Google Scholar 

  20. Alvisa-Negrín J, González-Reimers E, Santolaria-Fernández F et al (2009) Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol 44:468–475

    Article  PubMed  CAS  Google Scholar 

  21. Audran M, Cortet B (2011) Prevalence of osteoporosis in male patients with risk factors. Presse Med 40:e489–e498

    Article  PubMed  Google Scholar 

  22. Kizilgul M, Ozcelik O, Delibasi T (2016) Bone health and vitamin D status in alcoholic liver disease. Indian J Gastroenterol 35:253–259

    Article  CAS  PubMed  Google Scholar 

  23. Menecier P, Girard A, Badila P, Rotheval L, Lefranc D, Menecier-Ossia L (2009) Acute alcoholic intoxication at the hospital: a clinical stake. A prospective study of one year in a general hospital. Rev Med Interne 30:316–321

    Article  CAS  PubMed  Google Scholar 

  24. Mikosch P (2014) Alcohol and bone. Wien Med Wochenschr 164:15–24

    Article  PubMed  Google Scholar 

  25. Shankar K, Hidestrand M, Haley R et al (2006) Different molecular mechanisms underlie ethanol-induced bone loss in cycling and pregnant rats. Endocrinology 147:166–178

    Article  CAS  PubMed  Google Scholar 

  26. Wang Y, Li Y, Mao K, Li J, Cui Q, Wang GJ (2003) Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res 410:213–224

    Article  Google Scholar 

  27. Friday KE, Howard GA (1991) Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism 40:562–565

    Article  CAS  PubMed  Google Scholar 

  28. Jugdaohsingh R, O’Connell MA, Sripanyakorn S, Powell JJ (2006) Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proc Nutr Soc 65:291–310

    Article  CAS  PubMed  Google Scholar 

  29. Høidrup S, Grønbaek M, Gottschau A, Lauritzen JB, Schroll M (1999) Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 149:993–1001

    Article  PubMed  Google Scholar 

  30. Torricelli P, Fini M, Giavaresi G et al (2007) Intermittent exposure to ethanol vapor affects osteoblast behaviour more severely than estrogen deficiency does in vitro study on rat osteoblasts. Toxicology 237:168–176

    Article  CAS  PubMed  Google Scholar 

  31. Díez-Ruiz A, García-Saura PL, García-Ruiz P, González-Calvin JL, Gallego-Rojo F, Fuchs D (2010) Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol Alcohol 45:427–430

    Article  PubMed  CAS  Google Scholar 

  32. Cheung RC, Gray C, Boyde A, Jones SJ (1995) Effects of ethanol on bone cells in vitro resulting in increased resorption. Bone 16:143–147

    Article  CAS  PubMed  Google Scholar 

  33. Yao Z, Zhang J, Dai J, Keller ET (2001) Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells. Bone 28:167–173

    Article  CAS  PubMed  Google Scholar 

  34. García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F et al (2006) Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 41:261–266

    Article  PubMed  CAS  Google Scholar 

  35. Fábrega E, Orive A, García-Suarez C, García-Unzueta M, Antonio AJ, Pons-Romero F (2005) Osteoprotegerin and RANKL in alcoholic liver cirrhosis. Liver Int 25:305–310

    Article  PubMed  CAS  Google Scholar 

  36. Perrien DS, Brown EC, Fletcher TW et al (2002) Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis. J Pharmacol Exp Ther 303:904–908

    Article  CAS  PubMed  Google Scholar 

  37. Wahl EC, Aronson J, Liu L et al (2007) Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol 220:302–310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Shankar K, Hidestrand M, Liu X et al (2008) Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res 23:338–349

    Article  CAS  PubMed  Google Scholar 

  39. Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Badger TM, Ronis MJ (2010) A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling. J Bone Miner Res 25:1117–1127

    Article  CAS  PubMed  Google Scholar 

  40. Galli C, Passeri G, Macaluso GM (2010) Osteocytes and WNT: the mechanical control of bone formation. J Dent Res 89:331–343

    Article  CAS  PubMed  Google Scholar 

  41. Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606–615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Smith C, Gasparetto M, Jordan C, Pollyea DA, Vasiliou V (2015) The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis. Adv Exp Med Biol 815:349–359

    Article  CAS  PubMed  Google Scholar 

  43. Ronis MJ, Mercer K, Chen JR (2011) Effects of nutrition and alcohol consumption on bone loss. Curr Osteoporos Rep 9:53–59

    Article  PubMed  PubMed Central  Google Scholar 

  44. Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192

    Article  CAS  PubMed  Google Scholar 

  45. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  PubMed  Google Scholar 

  46. Liu Y, Kou X, Chen C et al (2016) Chronic high dose alcohol induces osteopenia via activation of mTOR signaling in bone marrow mesenchymal stem cells. Stem Cells 34:2157–2168

    Article  CAS  PubMed  Google Scholar 

  47. Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP (2013) mTOR kinase structure, mechanism and regulation. Nature 497:217–223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Martin SK, Fitter S, Dutta AK et al (2015) Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells 33:1359–1365

    Article  CAS  PubMed  Google Scholar 

  49. Dai Q, Xie F, Han Y et al (2017) Inactivation of regulatory-associated protein of mTOR (raptor)/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice. J Biol Chem 292:196–204

    Article  CAS  PubMed  Google Scholar 

  50. Dorgan JF, Reichman ME, Judd JT et al (1994) The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 5:53–60

    Article  CAS  PubMed  Google Scholar 

  51. Chen JR, Haley RL, Hidestrand M et al (2006) Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther 319:1182–1190

    Article  CAS  PubMed  Google Scholar 

  52. Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC (2003) Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 90:315–326

    Article  CAS  PubMed  Google Scholar 

  53. Syed F, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688–696

    Article  CAS  PubMed  Google Scholar 

  54. Chen JR, Plotkin LI, Aguirre JI et al (2005) Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens. J Biol Chem 280:4632–4638

    Article  CAS  PubMed  Google Scholar 

  55. Bai XC, Lu D, Liu AL et al (2005) Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 280:17497–17506

    Article  CAS  PubMed  Google Scholar 

  56. Lean JM, Davies JT, Fuller K et al (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Investig 112:915–923

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Díez A, Puig J, Serrano S et al (1994) Alcohol-induced bone disease in the absence of severe chronic liver damage. J Bone Miner Res 9:825–831

    Article  PubMed  Google Scholar 

  58. Malik P, Gasser RW, Kemmler G et al (2009) Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 33:375–381

    Article  CAS  PubMed  Google Scholar 

  59. Swarthout JT, D’Alonzo RC, Selvamurugan N, Partridge NC (2002) Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1–17

    Article  CAS  PubMed  Google Scholar 

  60. Lombardi G, Di SC, Rubino M et al (2011) The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. J Endocrinol Investig 34:18–22

    CAS  Google Scholar 

  61. Anderson PH, Sawyer RK, Moore AJ, May BK, O’Loughlin PD, Morris HA (2008) Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res 23:1789–1797

    Article  CAS  PubMed  Google Scholar 

  62. Baldock PA, Thomas GP, Hodge JM et al (2006) Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 21:1618–1626

    Article  CAS  PubMed  Google Scholar 

  63. Lang CH, Frost RA, Summer AD, Vary TC (2005) Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart. Int J Biochem Cell Biol 37:2180–2195

    Article  CAS  PubMed  Google Scholar 

  64. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854

    Article  CAS  PubMed  Google Scholar 

  65. Maurel DB, Boisseau N, Benhamou CL, Jaffre C (2012) Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int 23:1–16

    Article  CAS  PubMed  Google Scholar 

  66. Maddalozzo GF, Turner RT, Edwards CH et al (2009) Alcohol alters whole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 20:1529–1538

    Article  CAS  PubMed  Google Scholar 

  67. Lang CH, Fan J, Lipton BP, Potter BJ, McDonough KH (1998) Modulation of the insulin-like growth factor system by chronic alcohol feeding. Alcohol Clin Exp Res 22:823–829

    Article  CAS  PubMed  Google Scholar 

  68. Lang CH, Liu X, Nystrom G, Wu D, Cooney RN, Frost RA (2000) Acute effects of growth hormone in alcohol-fed rats. Alcohol Alcohol 35:148–158

    Article  CAS  PubMed  Google Scholar 

  69. Menagh PJ, Turner RT, Jump DB et al (2010) Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res 25:757–768

    CAS  PubMed  Google Scholar 

  70. Lang CH, Vary TC, Frost RA (2003) Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 144:3922–3933

    Article  CAS  PubMed  Google Scholar 

  71. Kumar V, Frost RA, Lang CH (2002) Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle. Am J Physiol Endocrinol Metab 283:E917–E928

    Article  CAS  PubMed  Google Scholar 

  72. Shah OJ, Anthony JC, Kimball SR, Jefferson LS (2000) 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab 279:E715–E729

    CAS  PubMed  Google Scholar 

  73. Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J (2007) Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res 31:1269–1285

    Article  CAS  PubMed  Google Scholar 

  74. Bakker AD, Gakes T, Hogervorst JM, de Wit GM, Klein-Nulend J, Jaspers RT (2016) Mechanical stimulation and IGF-1 enhance mRNA translation rate in osteoblasts via activation of the AKT-mTOR pathway. J Cell Physiol 231:1283–1290

    Article  CAS  PubMed  Google Scholar 

  75. Lang CH, Pruznak AM, Deshpande N, Palopoli MM, Frost RA, Vary TC (2004) Alcohol intoxication impairs phosphorylation of S6K1 and S6 in skeletal muscle independently of ethanol metabolism. Alcohol Clin Exp Res 28:1758–1767

    Article  CAS  PubMed  Google Scholar 

  76. Himes R, Wezeman FH, Callaci JJ (2008) Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis. Alcohol Clin Exp Res 32:1167–1180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Novitskiy G, Traore K, Wang L, Trush MA, Mezey E (2006) Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin Exp Res 30:1429–1435

    Article  CAS  PubMed  Google Scholar 

  78. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H (2007) Trends in oxidative aging theories. Free Radic Biol Med 43:477–503

    Article  CAS  PubMed  Google Scholar 

  79. Chen JR, Shankar K, Nagarajan S, Badger TM, Ronis MJ (2008) Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. J Pharmacol Exp Ther 324:50–59

    Article  CAS  PubMed  Google Scholar 

  80. Serrander L, Cartier L, Bedard K et al (2007) NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406:105–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Chen JR, Lazarenko OP, Shankar K et al (2011) Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther 336:734–742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Schröder K, Wandzioch K, Helmcke I, Brandes RP (2009) Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29:239–245

    Article  PubMed  CAS  Google Scholar 

  83. Colston JT, de la Rosa SD, Strader JR, Anderson MA, Freeman GL (2005) H2O2 activates Nox4 through PLA2-dependent arachidonic acid production in adult cardiac fibroblasts. FEBS Lett 579:2533–2540

    Article  CAS  PubMed  Google Scholar 

  84. Shankar K, Liu X, Singhal R et al (2008) Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). Endocrinology 149:1748–1756

    Article  CAS  PubMed  Google Scholar 

  85. Torres M (2003) Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8:d369–d391

    Article  CAS  PubMed  Google Scholar 

  86. O’Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC (1999) STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274:19301–19308

    Article  PubMed  Google Scholar 

  87. Wu RF, Ma Z, Myers DP, Terada LS (2007) HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem 282:37412–37419

    Article  CAS  PubMed  Google Scholar 

  88. Lee NK, Choi YG, Baik JY et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852–859

    Article  CAS  PubMed  Google Scholar 

  89. Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE (2006) Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 79:1348–1356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Yeh CH, Chang JK, Wang YH, Ho ML, Wang GJ (2008) Ethanol may suppress Wnt/beta-catenin signaling on human bone marrow stroma cells: a preliminary study. Clin Orthop Relat Res 466:1047–1053

    Article  PubMed  PubMed Central  Google Scholar 

  91. Marie PJ (2015) Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies. Cell Mol Life Sci 72:1347–1361

    Article  CAS  PubMed  Google Scholar 

  92. Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192

    Article  CAS  PubMed  Google Scholar 

  93. Paszty C, Turner CH, Robinson MK (2010) Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res 25:1897–1904

    Article  CAS  PubMed  Google Scholar 

  94. van Bezooijen RL, ten Dijke P, Papapoulos SE, Löwik CW (2005) SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16:319–327

    Article  PubMed  CAS  Google Scholar 

  95. González-Reimers E, Quintero-Platt G, Rodríguez-Rodríguez E, Martínez-Riera A, Alvisa-Negrín J, Santolaria-Fernández F (2015) Bone changes in alcoholic liver disease. World J Hepatol 7:1258–1264

    Article  PubMed  PubMed Central  Google Scholar 

  96. Cummings SR, San MJ, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765

    Article  CAS  PubMed  Google Scholar 

  97. Li J, Kim SG, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19:373–379

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Shaw RJ, Bardeesy N, Manning BD et al (2004) The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 6:91–99

    Article  CAS  PubMed  Google Scholar 

  99. Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483–510

    Article  CAS  PubMed  Google Scholar 

  100. Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster DA (2016) The enigma of rapamycin dosage. Mol Cancer Ther 15:347–353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Wezeman FH, Juknelis D, Himes R, Callaci JJ (2007) Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats. Bone 41:639–645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. López-Larramona G, Lucendo AJ, González-Delgado L (2013) Alcoholic liver disease and changes in bone mineral density. Rev Esp Enferm Dig 105:609–621

    Article  PubMed  Google Scholar 

  103. Wezeman FH, Emanuele MA, Moskal SF, Steiner J, Lapaglia N (2000) Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. J Bone Miner Res 15:2033–2041

    Article  CAS  PubMed  Google Scholar 

  104. Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C (2011) Bisphosphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst Rev 12:CD009144

    Google Scholar 

  105. Kouda K, Iki M, Fujita Y et al (2011) Alcohol intake and bone status in elderly Japanese men: baseline data from the Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone 49:275–280

    Article  CAS  PubMed  Google Scholar 

  106. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21–35

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Z., Liu, Y., Liu, Y. et al. Cellular and molecular mechanisms of alcohol-induced osteopenia. Cell. Mol. Life Sci. 74, 4443–4453 (2017). https://doi.org/10.1007/s00018-017-2585-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-017-2585-y

Keywords

Navigation